Matinas BioPharma Holdings Inc. appointed Jerome Jabbour as CEO and director, effective March 16.
Roelof Rongen has stepped down as CEO and as a member of the company's board as part of a planned transition. He had served as CEO of the company since July 2013.
Jabbour, who is a co-founder of Matinas, has served as president of the company since March 2016 and as executive vice president and chief business officer since 2013.
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications.
